Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Zeffix
Active Ingredient: Lamivudine 5mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer: Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom
Note: This consent is valid for 2 years from 17 September 2002.
Product: Zeffix
Active Ingredient: Lamivudine 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer: Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom
Note: This consent is valid for 2 years from 17 September 2002.
Dated this 28th day of March 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).